123 related articles for article (PubMed ID: 9580419)
1. Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.
Martín-Calderón JL; Muñoz RM; Villanúa MA; del Arco I; Moreno JL; de Fonseca FR; Navarro M
Eur J Pharmacol; 1998 Feb; 344(1):77-86. PubMed ID: 9580419
[TBL] [Abstract][Full Text] [Related]
2. Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.
del Arco I; Muñoz R; Rodríguez De Fonseca F; Escudero L; Martín-Calderón JL; Navarro M; Villanúa MA
Neuroimmunomodulation; 2000; 7(1):16-26. PubMed ID: 10601815
[TBL] [Abstract][Full Text] [Related]
3. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
Rodríguez de Fonseca FR; Villanúa MA; Muñoz RM; San-Martin-Clark O; Navarro M
Neuroendocrinology; 1995 Jun; 61(6):714-21. PubMed ID: 7659195
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
[TBL] [Abstract][Full Text] [Related]
7. Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization.
Lee TT; Wainwright SR; Hill MN; Galea LA; Gorzalka BB
Hippocampus; 2014 Mar; 24(3):280-92. PubMed ID: 24132958
[TBL] [Abstract][Full Text] [Related]
8. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of delta1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat.
Ayalon D; Nir I; Cordova T; Bauminger S; Puder M; Naor Z; Kashi R; Zor U; Harell A; Lindner HR
Neuroendocrinology; 1977; 23(1):31-42. PubMed ID: 331132
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
Bonnin A; Ramos JA; Rodríguez de Fonseca F; Cebeira M; Fernández-Ruiz JJ
Neuroendocrinology; 1993 Sep; 58(3):280-6. PubMed ID: 7902959
[TBL] [Abstract][Full Text] [Related]
11. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Murphy LL; Steger RW; Smith MS; Bartke A
Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.
Vidrio H; Sánchez-Salvatori MA; Medina M
J Cardiovasc Pharmacol; 1996 Aug; 28(2):332-6. PubMed ID: 8856492
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent inhibition of the preovulatory surges of gonadotropins and prolactin by the antiestrogen CI-628: possible sites of action.
De Paolo LV
Biol Reprod; 1985 May; 32(4):745-52. PubMed ID: 3924129
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
15. Atrazine disrupts the hypothalamic control of pituitary-ovarian function.
Cooper RL; Stoker TE; Tyrey L; Goldman JM; McElroy WK
Toxicol Sci; 2000 Feb; 53(2):297-307. PubMed ID: 10696778
[TBL] [Abstract][Full Text] [Related]
16. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
Gorriti MA; Rodríguez de Fonseca F; Navarro M; Palomo T
Eur J Pharmacol; 1999 Jan; 365(2-3):133-42. PubMed ID: 9988095
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models.
Ottani A; Ferrari F; Giuliani D
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):91-6. PubMed ID: 11853125
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute intermittent exposure to cigarette smoke on catecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and corticosterone.
Andersson K; Fuxe K; Eneroth P; Mascagni F; Agnati LF
Acta Physiol Scand; 1985 Jun; 124(2):277-85. PubMed ID: 2861716
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress.
Hill MN; Gorzalka BB
Eur J Pharmacol; 2004 Sep; 499(3):291-5. PubMed ID: 15381051
[TBL] [Abstract][Full Text] [Related]
20. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol.
Jackson AL; Murphy LL
Neuroendocrinology; 1997 Jun; 65(6):446-52. PubMed ID: 9208407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
